Keyphrases
Clinical Characteristics
100%
Atypical Antipsychotics
100%
Blonanserin
100%
Sertindole
100%
Lurasidone
100%
Asenapine
100%
Iloperidone
100%
Schizophrenia
60%
Antipsychotics
60%
Schizophrenia Treatment
60%
Treatment Options
40%
Tolerability
40%
Mental Illness
40%
Safety Self-efficacy
40%
Japan
20%
United States
20%
Cardiovascular Mortality
20%
Clinical Practice
20%
Potential Risk
20%
U.S. Food
20%
Patients with Schizophrenia
20%
Functional Capacity
20%
Economic Aspects
20%
Positive Symptoms
20%
Negative Symptoms
20%
Relapse Prevention
20%
European Market
20%
Unsuccessful Treatment
20%
Clinical Trial Data
20%
Cognitive Symptoms
20%
Socio-occupational Functioning
20%
Functional Economics
20%
Novel Antipsychotics
20%
Treatment-resistant
20%
Pharmacology, Toxicology and Pharmaceutical Science
Atypical Antipsychotics
100%
Blonanserin
100%
Asenapine
100%
Lurasidone
100%
Sertindole
100%
Iloperidone
100%
Tolerability
40%
Antipsychotic
40%
Typical Antipsychotic
40%
Deterioration
20%
Clinical Trial
20%
Functional Status
20%